Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
- PMID: 24794371
- PMCID: PMC4368900
- DOI: 10.1001/jama.2014.3201
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009
Abstract
Importance: Despite concern about an "epidemic," there are limited data on trends in prevalence of either type 1 or type 2 diabetes across US race and ethnic groups.
Objective: To estimate changes in the prevalence of type 1 and type 2 diabetes in US youth, by sex, age, and race/ethnicity between 2001 and 2009.
Design, setting, and participants: Case patients were ascertained in 4 geographic areas and 1 managed health care plan. The study population was determined by the 2001 and 2009 bridged-race intercensal population estimates for geographic sites and membership counts for the health plan.
Main outcomes and measures: Prevalence (per 1000) of physician-diagnosed type 1 diabetes in youth aged 0 through 19 years and type 2 diabetes in youth aged 10 through 19 years.
Results: In 2001, 4958 of 3.3 million youth were diagnosed with type 1 diabetes for a prevalence of 1.48 per 1000 (95% CI, 1.44-1.52). In 2009, 6666 of 3.4 million youth were diagnosed with type 1 diabetes for a prevalence of 1.93 per 1000 (95% CI, 1.88-1.97). In 2009, the highest prevalence of type 1 diabetes was 2.55 per 1000 among white youth (95% CI, 2.48-2.62) and the lowest was 0.35 per 1000 in American Indian youth (95% CI, 0.26-0.47) and type 1 diabetes increased between 2001 and 2009 in all sex, age, and race/ethnic subgroups except for those with the lowest prevalence (age 0-4 years and American Indians). Adjusted for completeness of ascertainment, there was a 21.1% (95% CI, 15.6%-27.0%) increase in type 1 diabetes over 8 years. In 2001, 588 of 1.7 million youth were diagnosed with type 2 diabetes for a prevalence of 0.34 per 1000 (95% CI, 0.31-0.37). In 2009, 819 of 1.8 million were diagnosed with type 2 diabetes for a prevalence of 0.46 per 1000 (95% CI, 0.43-0.49). In 2009, the prevalence of type 2 diabetes was 1.20 per 1000 among American Indian youth (95% CI, 0.96-1.51); 1.06 per 1000 among black youth (95% CI, 0.93-1.22); 0.79 per 1000 among Hispanic youth (95% CI, 0.70-0.88); and 0.17 per 1000 among white youth (95% CI, 0.15-0.20). Significant increases occurred between 2001 and 2009 in both sexes, all age-groups, and in white, Hispanic, and black youth, with no significant changes for Asian Pacific Islanders and American Indians. Adjusted for completeness of ascertainment, there was a 30.5% (95% CI, 17.3%-45.1%) overall increase in type 2 diabetes.
Conclusions and relevance: Between 2001 and 2009 in 5 areas of the United States, the prevalence of both type 1 and type 2 diabetes among children and adolescents increased. Further studies are required to determine the causes of these increases.
Conflict of interest statement
Comment in
-
Diabetes prevalence among youth.JAMA. 2014 Sep 17;312(11):1153. doi: 10.1001/jama.2014.9617. JAMA. 2014. PMID: 25226483 No abstract available.
-
Diabetes prevalence among youth--reply.JAMA. 2014 Sep 17;312(11):1153-4. doi: 10.1001/jama.2014.9620. JAMA. 2014. PMID: 25226484 No abstract available.
Similar articles
-
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.Pediatrics. 2006 Oct;118(4):1510-8. doi: 10.1542/peds.2006-0690. Pediatrics. 2006. PMID: 17015542
-
Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017.JAMA. 2021 Aug 24;326(8):717-727. doi: 10.1001/jama.2021.11165. JAMA. 2021. PMID: 34427600 Free PMC article.
-
Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014.Am J Obstet Gynecol. 2017 Feb;216(2):177.e1-177.e8. doi: 10.1016/j.ajog.2016.10.007. Epub 2016 Oct 15. Am J Obstet Gynecol. 2017. PMID: 27751798 Free PMC article.
-
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective.J Pediatr. 2000 May;136(5):664-72. doi: 10.1067/mpd.2000.105141. J Pediatr. 2000. PMID: 10802501 Review.
-
Ethnic issues in the epidemiology of childhood obesity.Pediatr Clin North Am. 2001 Aug;48(4):855-78. doi: 10.1016/s0031-3955(05)70345-x. Pediatr Clin North Am. 2001. PMID: 11494640 Review.
Cited by
-
Clinical utility of anti-Müllerian hormone in female children and adolescents.Hormones (Athens). 2024 Oct 31. doi: 10.1007/s42000-024-00603-5. Online ahead of print. Hormones (Athens). 2024. PMID: 39477856 Review.
-
Clinical Profile, Risk Factors, and Complications in Young-Onset Type 2 Diabetes Mellitus.Cureus. 2024 Sep 3;16(9):e68497. doi: 10.7759/cureus.68497. eCollection 2024 Sep. Cureus. 2024. PMID: 39364487 Free PMC article.
-
Developing a Physical Activity Program for Mothers and Their Children at Risk for Diabetes.Health Serv Res Manag Epidemiol. 2024 Sep 23;11:23333928241284178. doi: 10.1177/23333928241284178. eCollection 2024 Jan-Dec. Health Serv Res Manag Epidemiol. 2024. PMID: 39328808 Free PMC article.
-
Population-based prevalence of self-reported pediatric diabetes and screening for undiagnosed type 2 diabetes in Chinese children in years 2017-2019, a cross-sectional study.Lancet Reg Health West Pac. 2024 Sep 18;52:101206. doi: 10.1016/j.lanwpc.2024.101206. eCollection 2024 Nov. Lancet Reg Health West Pac. 2024. PMID: 39324120 Free PMC article.
-
Corrigendum to: Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Health Promot Perspect. 2020 Mar 30;10(2):98-115. doi: 10.34172/hpp.2020.18.Health Promot Perspect. 2024 Jul 29;14(2):202-205. doi: 10.34172/hpp.43143. eCollection 2024. Health Promot Perspect. 2024. PMID: 39291043 Free PMC article.
References
-
- Imperatore G, Boyle JP, Thompson TJ, et al. SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35 (12):2515–2520. - PMC - PubMed
-
- Patterson CC, Gyürüs E, Rosenbauer J, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of nonuniformity over time in rates of increase. Diabetologia. 2012;55 (8):2142–2147. - PubMed
-
- Vehik K, Hamman RF, Lezotte D, et al. Increasing incidence of type 1 diabetes in 0- to 17-year-old Colorado youth. Diabetes Care. 2007;30 (3):503–509. - PubMed
-
- Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA. 2013;310 (4):427–428. - PubMed
-
- Saydah S, Imperatore G, Geiss L, Gregg E Centers for Disease Control and Prevention. Diabetes death rates among youths aged ≤19 years—United States, 1968–2009. MMWR Morb Mortal Wkly Rep. 2012;61 (43):869–872. - PubMed
Publication types
MeSH terms
Grants and funding
- DP-05-069/DP/NCCDPHP CDC HHS/United States
- U48/CCU419249/PHS HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U48/CCU919219/PHS HHS/United States
- P30 DK57516/DK/NIDDK NIH HHS/United States
- UL1 TR00423/TR/NCATS NIH HHS/United States
- U48/CCU519239/PHS HHS/United States
- U18DP002710-01/DP/NCCDPHP CDC HHS/United States
- UL1 RR029882/RR/NCRR NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- P30 DK057516/DK/NIDDK NIH HHS/United States
- HIR 10-001/HX/HSRD VA/United States
- 1U18DP002709/DP/NCCDPHP CDC HHS/United States
- U48/CCU819241-3/PHS HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- U18 DP003256/DP/NCCDPHP CDC HHS/United States
- 8 UL1 TR000077/TR/NCATS NIH HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- U18DP002714/DP/NCCDPHP CDC HHS/United States
- U18DP002708-01/DP/NCCDPHP CDC HHS/United States
- 200-2010-35171/PHS HHS/United States
- DP-10-001/DP/NCCDPHP CDC HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- U18DP000247-06A1/DP/NCCDPHP CDC HHS/United States
- R01 DK104706/DK/NIDDK NIH HHS/United States
- U58/CCU019235-4/PHS HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- U18 DP006139/DP/NCCDPHP CDC HHS/United States
- K23 DK089017/DK/NIDDK NIH HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
- PA00097/PHS HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- UL1RR029882/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
